BoomerangFX Unveils Cutting-edge AI Search Advertising
BoomerangFX has officially announced the launch of its new AI-driven search advertising service, integrating the innovative features of OpenAI's ChatGPT into marketing strategies designed specifically for healthcare practices focused on aesthetic, wellness, and private-pay services. This groundbreaking development represents a seamless blend of advertising, search engine optimization, and patient engagement technologies tailored for modern clinical environments.
The newly introduced service will provide paid search advertising through ChatGPT, complemented by AI-enhanced search optimization specifically for Claude and Gemini platforms, combining various functionalities from lead generation and conversion workflows to payment processing all under one cohesive platform. As part of its initial rollout, the service will be available in the United States, Canada, and the United Kingdom starting November 2026, with future expansion plans into markets such as Ireland, Germany, Australia, India, and Latin America.
Redefining Patient Discovery in Healthcare
According to BoomerangFX, this offering will be the first of its kind, designed expressly for the healthcare sector to facilitate AI-based search advertising. With the increasing reliance on AI chatbots for medical inquiries—34% of U.S. adults reportedly use such tools for health-related questions according to Pew Research Center—the need for healthcare practices to be visible within these new channels is more crucial than ever. BoomerangFX aims to empower clinicians to convert this interest into booked consultations, thereby enhancing patient engagement and establishing long-term relationships.
Jerome Dwight, the co-founder and CEO of BoomerangFX, emphasized the significance of integrating AI-driven insights into lasting patient connections. He commented, “The next era of clinic growth will depend on how effectively practices leverage AI to foster enduring patient relationships.” The service aims to unify the elements of advertising, search engine optimization, patient communication, and clinical workflows into a single platform that aligns generated demand with the patient experience offered by healthcare providers.
Smart Website Intelligence: A Step Towards Enhanced Discoverability
Integral to the GROW product suite, the Smart Website Intelligence functions will enhance the findability of practices by organizing essential information like treatment expertise, physician qualifications, practice locations, and patient education into accessible website content. The proprietary Search Optimization Intelligence will utilize BoomerangFX's advanced data science to aid AI platforms in parsing and referencing this information as prospective patients conduct treatment searches.
Combining paid AI search ads on OpenAI's ChatGPT with website content and optimization for organic search through Claude and Gemini platforms, BoomerangFX guarantees that every visitor has a clear path to inquire about services, interact with the platform, and book appointments. This multipronged advertising model also embraces traditional platforms like Google, Meta, and Instagram to maximize visibility and reach.
Moreover, the AI-driven workflows within the AUVIA™ Clinic Co-Pilot facilitate immediate lead responses and personalized follow-ups, ensuring that queries are efficiently transformed into booked treatments with minimal manual input. Campaign signals and conversion rates feed back into ongoing optimizations, creating a direct link between marketing efforts and patient retention and appointment outcomes.
A Comprehensive System from Lead Inquiry to Ongoing Care
BoomerangFX brings together three integrated solutions designed to enhance operational efficiency:
- - RUN: An all-encompassing practice management and electronic medical record (EMR) solution that integrates scheduling, documentation, consent forms, treatment reports, e-prescribing, inventory management, and reporting with billing, payments, and patient financing. Memberships, service packages, and rescheduling options are also implemented to nurture long-term patient relationships.
- - GROW: This component focuses on lead generation, pipeline management, intelligent website analytics, and conversion workflows. Once demand is initiated through optimized advertising, AUVIA™ will engage potential patients with tailored multilingual chat features to facilitate inquiry qualification, consultation scheduling, payment processing, and automate reminders and follow-ups.
- - ELEVATE: The specialized marketing strategy within this model generates demand through targeted marketing, intelligent website optimization, and continuous campaign refinement that aligns with each practice's growth objectives.
Together, these solutions enable practices to manage the entire patient journey—from the initial inquiry to documentation, compliance, payment processing, and continued care—by providing a coordinated operational framework that aims to improve conversion rates and maximize the lifetime value of each patient.
A Strategic Advantage Leveraging Specialized Data Science
The launch of this sophisticated service builds upon BoomerangFX's extensive experience, having executed over 10,000 campaigns across Google, Meta, and Instagram over the last decade. Employing proprietary machine learning models and data science expertise, the company combines marketing proficiency with focused context and performance analytics to refine campaign development and execution.
AUVIA™'s knowledge base includes over 2,000 entries concerning specialized treatments and clinical indications, encompassing nomenclature, treatment modalities, and issues like skin light damage, sagging skin, and pigmentation disorders. This context allows for effective patient communication while maintaining that clinical assessments and treatment choices rest firmly with licensed practitioners.
A Commitment to Innovation in Aesthetic Medicine
The clinical guidelines guiding this initiative reflect the expertise of BoomerangFX's medical advisory board led by Dr. Stephen Mulholland, a renowned aesthetic surgeon and co-founder of InMode, characterized by his contributions to the company’s NASDAQ IPO in 2019. Dr. Mulholland also pioneered several advanced treatment technologies such as Morpheus8, BodyTite, FaceTite, and AccuTite.
He highlighted, “Aesthetic and wellness practices require technologies that comprehend their field's language and their patients' expectations. Integrating specialized marketing with responsive communication and comprehensive patient records enables practices to offer a consistent experience from initial query to ongoing treatment.”
Availability and Future Prospects
This advanced advertising service will be released in November 2026 under the GROW Platinum tier, initially targeting markets in the U.S., Canada, and the U.K., with planned expansions to include Ireland, Germany, Australia, India, and Latin America. Existing BoomerangFX RUN and GROW customers will have the option to upgrade to this cutting-edge platform that enhances healthcare practices’ capabilities to acquire, address, and manage patient interactions more effectively.
For further details, visit
boomerangfx.com.
BoomerangFX aims to become the foundational operational platform for privately funded healthcare on a global scale, blending innovative technology with insightful marketing strategies to serve healthcare providers across numerous markets. Through international operations encompassing Miami, Toronto, London, and Sydney, the company is poised to redefine how healthcare practices engage with patients and manage their services.